Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-14-028988

← back to feed
Filed
May 9, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 7, 2014 21.63M sh
Stockholders Equity Q1 2014 · Mar 31, 2014 −$3.43M
Stockholders Equity Q1 2014 · Dec 31, 2013 −$3.12M
Current Liabilities Q1 2014 · Mar 31, 2014 $3.51M
Current Liabilities Q1 2014 · Dec 31, 2013 $3.22M
Current Assets Q1 2014 · Mar 31, 2014 $80.82K
Current Assets Q1 2014 · Dec 31, 2013 $95.84K
Total Assets Q1 2014 · Mar 31, 2014 $80.82K
Total Assets Q1 2014 · Dec 31, 2013 $96.32K
Cash And Equivalents Q1 2014 · Mar 31, 2013 $224.63K
Cash And Equivalents Q1 2014 · Dec 31, 2012 $511.69K
Sga Expense Q1 2014 · Mar 31, 2013 $156.83K
Rd Expense Q1 2014 · Mar 31, 2013 $237.82K
Net Income Q1 2014 · Mar 31, 2013 −$448.19K
Revenue Q1 2014 · Mar 31, 2013 $0